Reviewing of term sheet for licensing technology for Aptimmune Biologics

Collyer Law advised Aptimmune Biologics, Inc, a US based company which specializes in developing revolutionary mucosal vaccines, made with Barricade (TM) Formulation Technology, in connection with reviewing of term sheet for licensing technology.

Featured Posts
Recent Posts